Grant: Discovery Grants Program - Individual
École Polytechnique de Montréal
$25,020.00
Serum factors that mediate cell internalization of biomaterial scaffolds
EF 2008-09
Résumé
Walking around on damaged cartilage can lead to joint degeneration, pain, loss of mobility, and ultimately the need for joint replacement with a plastic and metal prosthesis. Although a total joint replacement can alleviate pain, one major downside is that patients with knee replacements have to stop running and jumping. This is why orthopedic surgeons have developed techniques to stimulate cartilage repair but many times these therapies fall short of complete success. Our ultimate research aim is to develop reliable, one-shot cartilage repair therapies, as simple off-the-shelf products that can be used throughout Canadian out-patient clinics by orthopedic surgeons. We recently discovered that blood clot implants stabilized with a polymer called chitosan can help regenerate cartilage. To better understand how this works, we plan to take serum that weeps out of blood clots, and mix it with chitosan, and see how serum changes the size of the chitosan particles. We noticed that serum somehow helps chitosan get inside of cells, and we believe that the way repair cells recognize and react to chitosan depends on how tightly certain serum proteins bind to the polymer. We also would like to see whether chitosan helps a clotting factor called thrombin to chop up complement protein to generate a potent protein fragment called complement C5a. Complement C5a could help repair damaged cartilage by recruiting cells called macrophages that cleanse the wound of debris and dead cells, and pave the way for new tissue to grow with a healthy blood supply. Finally, we plan to test how combinations of chitosan, serum factors, and bone marrow cells can be used to guide wound-healing macrophages to damaged cartilage. This molecules-to-tissues approach will improve our general understanding of how to regenerate cartilage using one-shot therapeutic devices.
)
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
262874-2008
Name nom
Hoemann, Caroline
Department département
Génie chimique
Organization id
64
Institution établissement
École Polytechnique de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2008
Award amount
25020
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
4
Committee name en
Chem. & Metallurgical Eng.
Committee name fr
Génies chimique et métal.
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
1
Nb partie
1
Application title
Serum factors that mediate cell internalization of biomaterial scaffolds
Keyword
NA
Application summary
Walking around on damaged cartilage can lead to joint degeneration, pain, loss of mobility, and ultimately the need for joint replacement with a plastic and metal prosthesis. Although a total joint replacement can alleviate pain, one major downside is that patients with knee replacements have to stop running and jumping. This is why orthopedic surgeons have developed techniques to stimulate cartilage repair but many times these therapies fall short of complete success. Our ultimate research aim is to develop reliable, one-shot cartilage repair therapies, as simple off-the-shelf products that can be used throughout Canadian out-patient clinics by orthopedic surgeons. We recently discovered that blood clot implants stabilized with a polymer called chitosan can help regenerate cartilage. To better understand how this works, we plan to take serum that weeps out of blood clots, and mix it with chitosan, and see how serum changes the size of the chitosan particles. We noticed that serum somehow helps chitosan get inside of cells, and we believe that the way repair cells recognize and react to chitosan depends on how tightly certain serum proteins bind to the polymer. We also would like to see whether chitosan helps a clotting factor called thrombin to chop up complement protein to generate a potent protein fragment called complement C5a. Complement C5a could help repair damaged cartilage by recruiting cells called macrophages that cleanse the wound of debris and dead cells, and pave the way for new tissue to grow with a healthy blood supply. Finally, we plan to test how combinations of chitosan, serum factors, and bone marrow cells can be used to guide wound-healing macrophages to damaged cartilage. This molecules-to-tissues approach will improve our general understanding of how to regenerate cartilage using one-shot therapeutic devices.
)